pharmadog

News

when

Latest
Archive

by source

All Sources
Sources Page

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
search

calendar

31,077 catalysts · 18,435 approval · 4,570 device 510k · 3,381 grant · 1,935 device recall · 1,751 device pma · 1,005 recall

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

to 2026-02-27×clear all

type

approval18,435
device 510k4,570
grant3,381
device recall1,935
device pma1,751
recall1,005
earnings4

therapy area

no tagged catalysts yet

Week of Aug 21, 2023

›Aug 25, 2023approval1104d agoLISDEXAMFETAMINE DIMESYLATE — FDA approvalLISDEXAMFETAMINE DIMESYLATE

Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL

full page →LISDEXAMFETAMINE DIMESYLATE →fda approvals ↗

›Aug 25, 2023approval1104d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

›Aug 25, 2023approval1104d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Week of Aug 28, 2023

›Aug 28, 2023approval1101d agoREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalluspatercept

Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS

full page →luspatercept →fda approvals ↗

›Aug 29, 2023approval

Week of Sep 4, 2023

›Sep 5, 2023approval1093d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 5, 2023approval

Week of Sep 11, 2023

›Sep 11, 2023approval1087d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

›Sep 11, 2023approval

Week of Sep 18, 2023

›Sep 20, 2023approval1078d agoNEXLETOL (BEMPEDOIC ACID) — FDA approvalbempedoic acid

Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL

full page →bempedoic acid →fda approvals ↗

›Sep 20, 2023approval

← prev

page 280 of 622

1100d ago

MYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL

full page →MYCOPHENOLATE MOFETIL →fda approvals ↗

›Aug 29, 2023approval1100d agoISOTRETINOIN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Aug 31, 2023approval1098d agoMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalSpexotras

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →Spexotras →fda approvals ↗

›Aug 31, 2023approval1098d agoTAFINLAR (DABRAFENIB MESYLATE) — FDA approvaldabrafenib mesylate ODT

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →dabrafenib mesylate ODT →fda approvals ↗

›Aug 31, 2023approval1098d agoALVIMOPAN — FDA approvalALVIMOPAN

Sponsor: HIKMA. Form: CAPSULE. Route: ORAL

full page →ALVIMOPAN →fda approvals ↗

1093d ago

DOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 5, 2023approval1093d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 5, 2023approval1093d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 5, 2023approval1093d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 5, 2023approval1093d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 6, 2023approval1092d agoYUFLYMA (ADALIMUMAB-AATY) — FDA approvalYUFLYMA

Sponsor: CELLTRION. Form: INJECTABLE. Route: INJECTION

full page →YUFLYMA →fda approvals ↗

›Sep 8, 2023approval1090d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Sep 8, 2023approval1090d agoAPHEXDA (MOTIXAFORTIDE ACETATE) — FDA approvalBioLineRx Ltd.

Sponsor: AYRMID PHARMA. Form: POWDER. Route: SUBCUTANEOUS

full page →fda approvals ↗

›Sep 8, 2023approval1090d agoHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalHYRIMOZ

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

full page →HYRIMOZ →fda approvals ↗

1087d ago

VORICONAZOLE — FDA approvalMylan Pharmaceuticals Inc